Delivery Order SPE2DB22D2206-SPE2DB25FJF57
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $35,744.11 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price, competitively awarded contract is set to be completed by July 24, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded procurement. This...
- The Defense Logistics Agency awarded a $79,278.21 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed-price contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside delivery order issued under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The place of performance is the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine, with a ceiling value of $6,449.00. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $20,877.50 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Menveo (meningococcal vaccine) in single-dose vial formulation (0.5 mL). This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of MENVEO 1 Vial (A-C-Y-W-135-DIP) 0.5mL meningococcal vaccine with a ceiling value of $1,891.26. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, and is scheduled for completion by July 23, 2025. This delivery order is a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,732.25 for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This competitively awarded, non-set-aside contract utilized firm fixed pricing and was completed on July 25, 2025, just one day after the award date of July 24, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which aligns with AmerisourceBergen's corporate headquarters location. This delivery...
- The Defense Logistics Agency awarded a $262,572.45 delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products. The contract, with a completion date of July 23, 2025, represents a competitive, non-set-aside award utilizing firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJF57Delivery Order
The Defense Logistics Agency awarded a $5,553.09 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 5, 2025. The contract is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and a major distribution center for pharmaceutical products. This delivery order represents a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supports the Defense Health Agency and other federal healthcare systems by supplying critical medical commodities, including vaccines, specialty medications, and medical supplies across multiple therapeutic domains. The company's contract portfolio demonstrates its capability to fulfill federal procurement requirements for pharmaceutical and medical products serving military and veteran healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/4/25 |